Evidence map›Paper›PMID 42897264›Full record

ArticleMolecular psychiatry2026

Shared cortical morphometry and molecular signatures across depression and physical diseases.

Chenguang Jiang, Hongliang Zhou, Yucheng Yuan, Wei Xu, Yue Zhou, Taipeng Sun, Linlin You, Suzhen Chen, Yingying Yin, Yingying Yue and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Chenguang Jiang *Department of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.ORCID http://orcid.org/0000-0003-4369-6645
Hongliang Zhou *Department of Medical Psychology, The Affiliated Hospital of Jiangnan University, Wuxi, China.
Yucheng Yuan *Huai'an No 3 People's Hospital, Huai'an, China.ORCID http://orcid.org/0000-0001-5812-9542
Wei XuDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.
Yue ZhouDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.
Taipeng SunDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.
Linlin YouDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.
Suzhen ChenDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.
Yingying YinDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.
Yingying YueDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.
Xiaoyun LiuDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.
Guangwei SunDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.
Yubo ZhangDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.
Jiacheng TanDepartment of Gastroenterology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
Ruihua ShiDepartment of Gastroenterology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
Xiaoyan XuDepartment of Rheumatology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
Zhi XuDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.ORCID http://orcid.org/0000-0003-0784-1702
Zhenhe ZhouDepartment of Psychiatry, the Affiliated Mental Health Center of Jiangnan University, Wuxi, China.
Wenbin GuoDepartment of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.ORCID http://orcid.org/0000-0002-1626-2465
Wenhao JiangDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China. wjiang43@outlook.com.ORCID http://orcid.org/0000-0001-9169-3487
Yonggui YuanDepartment of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China. 101011406@seu.edu.cn.ORCID http://orcid.org/0000-0001-6496-3998

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82271570
6 · The paper itself

Abstract

Major depressive disorder (MDD) is highly comorbid with physical diseases, suggesting shared neurobiological mechanisms. However, the common structural and molecular substrates underlying this comorbidity remain poorly understood. We analyzed multimodal MRI data from 577 patients (MDD, asthma, fibromyalgia, gastroesophageal reflux disease, type 2 diabetes) and 275 healthy controls, constructed individual morphometric similarity networks (MSN) to identify shared cortical alterations, and applied principal component analysis with multiscale molecular annotation (transcriptomic, cell-type, neurotransmitter, and cognitive mapping) to characterize underlying mechanisms. All patient groups exhibited regional MSN abnormalities. A shared MSN pattern emerged, featuring increased similarity in visual and somatomotor regions and decreased similarity in ventral attention, limbic, and default mode networks, and was replicated in independent cohorts. This pattern was significantly associated with spatial gene expression enriched for synaptic signaling, membrane potential regulation, and neuronal architecture, with predominant expression in excitatory/inhibitory neurons and astrocytes. It further mapped onto specific neurotransmitter systems, with exploratory cognitive decoding suggesting possible relevance to emotion and social cognition. Related genes overlapped with known risk loci for Alzheimer's disease and bipolar disorder. These findings identify a robust across diseases cortical MSN phenotype linked to convergent molecular and neurochemical correlates, offering a framework for studying shared vulnerability and transdiagnostic mechanisms across depression and physical diseases.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.